Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors.
Pires ES, D'Souza RS, Needham MA, Herr AK, Jazaeri AA, Li H, Stoler MH, Anderson-Knapp KL, Thomas T, Mandal A, Gougeon A, Flickinger CJ, Bruns DE, Pollok BA, Herr JC.
Pires ES, et al. Among authors: stoler mh.
Oncotarget. 2015 Oct 6;6(30):30194-211. doi: 10.18632/oncotarget.4734.
Oncotarget. 2015.
PMID: 26327203
Free PMC article.